Skip to main content

We are thrilled to announce our participation in BOS (Biotech Outsourcing Strategies) Manchester 2024, November 26-27.  

BOS Manchester 2024’s scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities. It brings together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships.  

You will find us at Booth 33, where our Business Development Associate Directors Monica Delgado and João Madeira do Ó will be representing AGC Pharma Chemicals. With decades of experience in Small Molecule API development, our team is ready to discuss how we can help accelerate your pharmaceutical projects. 

Whether you’re looking for seamless scale-up solutions, innovative process development, or flexible supply chain management, we have the expertise to support your needs. Join us in Manchester to explore new possibilities and discuss how we can partner for success in your next venture! 

 

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend CPHI Japan 2026
8th April 2026

AGC Pharma Chemicals to Attend CPHI Japan 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
Events & ConventionsAGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026
31st March 2026

AGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026

Best in Class distinctions for Overall Staff, Cultural Fit, Technology Use, and Scaling Support. Recognition within the Small/Mid-Size Small Molecule API group. Barcelona, March 30, 2026 – AGC Pharma Chemicals has…
How Reactors Work in a CDMO for Small Molecule APIsAll of ArticlesCDMO ProcessesCDMO TechnologyHow Reactors Work in a CDMO for Small Molecule APIs
13th March 2026

How Reactors Work in a CDMO for Small Molecule APIs

In a pharmaceutical Contract Development and Manufacturing Organization (CDMO), reactors are the foundational equipment where chemical reactions convert raw materials into intermediates and Active Pharmaceutical Ingredients (APIs) under tightly controlled…